-
balancing selection in the flavin-containing
monooxygenase 3 gene (FMO3)".
Pharmacogenet Genomics. 17 (10): 827–39. doi:10.1097/FPC.0b013e328256b198. PMID 17885620...
-
genetic basis for fluoroquinolone-induced
retinal degeneration in cats".
Pharmacogenet Genomics. 21 (2): 66–75. doi:10.1097/FPC.0b013e3283425f44. PMID 21150813...
- "Functional
characterization of
human xanthine oxidase allelic variants".
Pharmacogenet Genomics. 18 (3): 243–51. doi:10.1097/FPC.0b013e3282f55e2e. PMID 18300946...
- "PharmGKB summary: very
important pharmacogene information for UGT1A1".
Pharmacogenet Genomics. 24 (3): 177–83. doi:10.1097/FPC.0000000000000024. PMC 4091838...
- (November 2013). "PharmGKB summary:
tamoxifen pathway, pharmacokinetics".
Pharmacogenet Genomics. 23 (11): 643–7. doi:10.1097/FPC.0b013e3283656bc1. PMC 4084801...
- Stevens–Johnson
syndrome and
toxic epidermal necrolysis in a Thai po****tion".
Pharmacogenet Genomics. 19 (9): 704–9. doi:10.1097/FPC.0b013e328330a3b8. PMID 19696695...
- 5'-monophosphate
dehydrogenase 2 is ****ociated with
diminished enzyme activity".
Pharmacogenet. Genomics. 17 (4): 283–90. doi:10.1097/FPC.0b013e328012b8cf. PMID 17496727...
-
effects of alpha2C-adrenoreceptor gene
polymorphism in
healthy humans".
Pharmacogenet. Genomics. 15 (3): 143–9. doi:10.1097/01213011-200503000-00002. PMID 15861038...
-
method for
detection of CES1A1 and CES1A2/CES1A3
genetic variants".
Pharmacogenet Genomics. 22 (3): 215–8. doi:10.1097/FPC.0b013e32834f03eb. PMC 3412537...
-
alters agonist-promoted
desensitization of beta2-adrenergic receptors".
Pharmacogenet Genomics. 18 (8): 729–732. doi:10.1097/FPC.0b013e32830967e9. PMC 2699179...
